Advertisement

Abdominal Radiology

, Volume 42, Issue 6, pp 1695–1704 | Cite as

CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma

  • Ying Zhou
  • Lan He
  • Yanqi Huang
  • Shuting Chen
  • Penqi Wu
  • Weitao Ye
  • Zaiyi Liu
  • Changhong Liang
Article

Abstract

Purpose

To develop a CT-based radiomics signature and assess its ability for preoperatively predicting the early recurrence (≤1 year) of hepatocellular carcinoma (HCC).

Methods

A total of 215 HCC patients who underwent partial hepatectomy were enrolled in this retrospective study, and all the patients were followed up at least within 1 year. Radiomics features were extracted from arterial- and portal venous-phase CT images, and a radiomics signature was built by the least absolute shrinkage and selection operator (LASSO) logistic regression model. Preoperative clinical factors associated with early recurrence were evaluated. A radiomics signature, a clinical model, and a combined model were built, and the area under the curve (AUC) of operating characteristics (ROC) was used to explore their performance to discriminate early recurrence.

Results

Twenty-one radiomics features were chosen from 300 candidate features to build a radiomics signature that was significantly associated with early recurrence (P < 0.001), and they presented good performance in the discrimination of early recurrence alone with an AUC of 0.817 (95% CI: 0.758–0.866), sensitivity of 0.794, and specificity of 0.699. The AUCs of the clinical and combined models were 0.781 (95% CI: 0.719–0.834) and 0.836 (95% CI: 0.779–0.883), respectively, with the sensitivity being 0.784 and 0.824, and the specificity being 0.619 and 0.708, respectively. Adding a radiomics signature into conventional clinical variables can significantly improve the accuracy of the preoperative model in predicting early recurrence (P = 0.01).

Conclusions

The radiomics signature was a significant predictor for early recurrence in HCC. Incorporating radiomics signature into conventional clinical factors performed better for preoperative estimation of early recurrence than with clinical variables alone.

Keywords

Hepatocellular carcinoma Computed tomography Radiomics signature Predictor Recurrence 

Notes

Acknowledgments

We deeply appreciated the Medical Record Management Center for its close cooperation in data collection, sorting, verification, and database creation.

Compliance with ethical standards

Funding

This study was funded by the National Natural Scientific Foundation of China (Grant Numbers: 81271569, 81271654 and U1301258).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Informed consent

Statement of informed consent was not applicable since the article does not contain any patient data.

Supplementary material

261_2017_1072_MOESM1_ESM.docx (31 kb)
Supplementary material 1 (DOCX 30 kb)

References

  1. 1.
    Chen W, Zheng R, Baade PD, et al. (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132. doi: 10.3322/caac.21338 CrossRefPubMedGoogle Scholar
  2. 2.
    Clavien PA, Lesurtel M, Bossuyt PM, et al. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13(1):e11–e22. doi: 10.1016/s1470-2045(11)70175-9 CrossRefPubMedGoogle Scholar
  3. 3.
    Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150(4):835–853. doi: 10.1053/j.gastro.2015.12.041 CrossRefPubMedGoogle Scholar
  4. 4.
    Sangiovanni A, Colombo M (2016) Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int 36(Suppl 1):124–129. doi: 10.1111/liv.13028 CrossRefPubMedGoogle Scholar
  5. 5.
    Torzilli G, Donadon M, Marconi M, et al. (2008) Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Archiv Surg (Chicago, IL: 1960) 143(11):1082–1090. doi: 10.1001/archsurg.143.11.1082 Google Scholar
  6. 6.
    Torzilli G, Belghiti J, Kokudo N, et al. (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg 257(5):929–937. doi: 10.1097/SLA.0b013e31828329b8 CrossRefPubMedGoogle Scholar
  7. 7.
    Hsu CY, Hsia CY, Huang YH, et al. (2012) Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann Surg Oncol 19(3):842–849. doi: 10.1245/s10434-011-2060-1 CrossRefPubMedGoogle Scholar
  8. 8.
    Yang T, Lin C, Zhai J, et al. (2012) Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol 138(7):1121–1129. doi: 10.1007/s00432-012-1188-0 CrossRefPubMedGoogle Scholar
  9. 9.
    Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3):373–382CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Shimozawa N, Hanazaki K (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198(3):356–365. doi: 10.1016/j.jamcollsurg.2003.10.017 CrossRefPubMedGoogle Scholar
  11. 11.
    Shah SA, Cleary SP, Wei AC, et al. (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141(3):330–339. doi: 10.1016/j.surg.2006.06.028 CrossRefPubMedGoogle Scholar
  12. 12.
    Poon RT, Fan ST, Ng IO, et al. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89(3):500–507CrossRefPubMedGoogle Scholar
  13. 13.
    Shimada M, Takenaka K, Gion T, et al. (1996) Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111(3):720–726CrossRefPubMedGoogle Scholar
  14. 14.
    Hosaka T, Ikeda K, Kobayashi M, et al. (2009) Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma. Liver Int 29(5):736–742. doi: 10.1111/j.1478-3231.2008.01901.x CrossRefPubMedGoogle Scholar
  15. 15.
    Shah SA, Greig PD, Gallinger S, et al. (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202(2):275–283. doi: 10.1016/j.jamcollsurg.2005.10.005 CrossRefPubMedGoogle Scholar
  16. 16.
    Li T, Qin LX, Gong X, et al. (2014) Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery 156(3):651–660. doi: 10.1016/j.surg.2014.04.008 CrossRefPubMedGoogle Scholar
  17. 17.
    Li T, Wang SK, Zhou J, et al. (2016) Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC. Liver Int 36(2):284–292. doi: 10.1111/liv.12898 CrossRefPubMedGoogle Scholar
  18. 18.
    Pawlik TM, Gleisner AL, Anders RA, et al. (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245(3):435–442. doi: 10.1097/01.sla.0000250420.73854.ad CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Young AL, Lodge JP (2009) Needle-track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 58(6):887–888PubMedGoogle Scholar
  20. 20.
    Segal E, Sirlin CB, Ooi C, et al. (2007) Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 25(6):675–680. doi: 10.1038/nbt1306 CrossRefPubMedGoogle Scholar
  21. 21.
    Lambin P, Rios-Velazquez E, Leijenaar R, et al. (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (Oxford, England: 1990) 48(4):441–446. doi: 10.1016/j.ejca.2011.11.036 CrossRefGoogle Scholar
  22. 22.
    Aerts HJ, Velazquez ER, Leijenaar RT, et al. (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. doi: 10.1038/ncomms5006 PubMedPubMedCentralGoogle Scholar
  23. 23.
    Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22(4):796–802. doi: 10.1007/s00330-011-2319-8 CrossRefPubMedGoogle Scholar
  24. 24.
    Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266(1):177–184. doi: 10.1148/radiol.12120254 CrossRefPubMedGoogle Scholar
  25. 25.
    Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67(2):157–164. doi: 10.1016/j.crad.2011.08.012 CrossRefPubMedGoogle Scholar
  26. 26.
    Coroller TP, Grossmann P, Hou Y, et al. (2015) CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol 114(3):345–350. doi: 10.1016/j.radonc.2015.02.015 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Huang YQ, Liang CH, He L, et al. (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol . doi: 10.1200/jco.2015.65.9128 Google Scholar
  28. 28.
    Liang C, Huang Y, He L, et al. (2016) The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I–II and stage III–IV colorectal cancer. Oncotarget . doi: 10.18632/oncotarget.8919 Google Scholar
  29. 29.
    Chang PE, Ong WC, Lui HF, Tan CK (2008) Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 43(11):881–888. doi: 10.1007/s00535-008-2238-x CrossRefPubMedGoogle Scholar
  30. 30.
    Lam CM, Chan AO, Ho P, et al. (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients—implications for screening. Aliment Pharmacol Ther 19(7):771–777. doi: 10.1111/j.1365-2036.2004.01912.x CrossRefPubMedGoogle Scholar
  31. 31.
    Banerjee S, Wang DS, Kim HJ, et al. (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology (Baltimore, MD) 62(3):792–800. doi: 10.1002/hep.27877 CrossRefGoogle Scholar
  32. 32.
    Ganeshan B, Miles KA, Young RC, Chatwin CR (2009) Texture analysis in non-contrast enhanced CT: impact of malignancy on texture in apparently disease-free areas of the liver. Eur J Radiol 70(1):101–110. doi: 10.1016/j.ejrad.2007.12.005 CrossRefPubMedGoogle Scholar
  33. 33.
    Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143. doi: 10.1102/1470-7330.2010.0021 CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Jr HF (2015) Regression modeling strategies with applications to linear models, logistic and ordinal regression, and survival analysis. New York, NY: Springer-VerlagGoogle Scholar
  35. 35.
    Sauerbrei W, Royston P, Binder H (2007) Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26(30):5512–5528. doi: 10.1002/sim.3148 CrossRefPubMedGoogle Scholar
  36. 36.
    Zimmerman MA, Ghobrial RM, Tong MJ, et al. (2008) Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Archiv Surg (Chicago, IL: 1960) 143(2):182–188 (discussion 188). doi: 10.1001/archsurg.2007.39 Google Scholar
  37. 37.
    Richards CH, Mohammed Z, Qayyum T, Horgan PG, McMillan DC (2011) The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol (London, England) 7(10):1223–1235. doi: 10.2217/fon.11.99 CrossRefGoogle Scholar
  38. 38.
    Wang Y, Liao J, Qi W, Xie L, Li Y (2016) Predictive value of conventional ultrasound and contrast-enhanced ultrasound in early recurrence of hepatocellular carcinoma after surgical resection. Ultrasound Med Biol . doi: 10.1016/j.ultrasmedbio.2015.12.010 Google Scholar
  39. 39.
    Chen C-H, Chang T-T, Cheng K-S, et al. (2006) Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 26(7):766–773. doi: 10.1111/j.1478-3231.2006.01309.x CrossRefPubMedGoogle Scholar
  40. 40.
    Qi X, Liu L, Wang D, et al. (2015) Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 6(34):36838–36859. doi: 10.18632/oncotarget.5426 PubMedPubMedCentralGoogle Scholar
  41. 41.
    Mathurin P, Raynard B, Dharancy S, et al. (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17(10):1247–1261CrossRefPubMedGoogle Scholar
  42. 42.
    Agopian VG, Harlander-Locke M, Zarrinpar A, et al. (2015) A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg 220(4):416–427. doi: 10.1016/j.jamcollsurg.2014.12.025 CrossRefPubMedGoogle Scholar
  43. 43.
    Ng F, Kozarski R, Ganeshan B, Goh V (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82(2):342–348. doi: 10.1016/j.ejrad.2012.10.023 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Ying Zhou
    • 1
    • 2
    • 3
  • Lan He
    • 4
  • Yanqi Huang
    • 2
  • Shuting Chen
    • 1
    • 2
  • Penqi Wu
    • 1
    • 2
  • Weitao Ye
    • 2
  • Zaiyi Liu
    • 1
    • 2
  • Changhong Liang
    • 1
    • 2
  1. 1.Graduate CollegeSouthern Medical UniversityGuangzhouChina
  2. 2.Department of Radiology, Guangdong General HospitalGuangdong Academy of Medical SciencesGuangzhouChina
  3. 3.Department of RadiologyMianyang Central HospitalMianyangChina
  4. 4.School of MedicineSouth China University of TechnologyGuangzhouChina

Personalised recommendations